Vesicoamniotic shunting for fetal megacystis in the first trimester with a Somatex(®) intrauterine shunt

PURPOSE: The objective was to evaluate the feasibility of vesicoamniotic shunting (VAS) in the first trimester with the Somatex(®) intrauterine shunt and report on complications and neonatal outcome. METHODS: Retrospective cohort study of all VAS before 14 weeks at two tertiary fetal medicine centre...

Descripción completa

Detalles Bibliográficos
Autores principales: Strizek, B., Gottschalk, I., Recker, F., Weber, E., Flöck, A., Gembruch, U., Geipel, A., Berg, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Maternal-Fetal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266802/
https://www.ncbi.nlm.nih.gov/pubmed/32449061
http://dx.doi.org/10.1007/s00404-020-05598-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266802/
https://www.ncbi.nlm.nih.gov/pubmed/32449061
http://dx.doi.org/10.1007/s00404-020-05598-z

Ejemplares similares